Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding
about
Drug combinations against Borrelia burgdorferi persisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycyclineNew Is Old, and Old Is New: Recent Advances in Antibiotic-Based, Antibiotic-Free and Ethnomedical Treatments against Methicillin-Resistant Staphylococcus aureus Wound InfectionsMechanisms of drug resistance: daptomycin resistanceCeftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model.Phenol soluble modulin (PSM) variants of community-associated methicillin-resistant Staphylococcus aureus (MRSA) captured using mass spectrometry-based molecular networking.Human cathelicidin LL-37 resistance and increased daptomycin MIC in methicillin-resistant Staphylococcus aureus strain USA600 (ST45) are associated with increased mortality in a hospital setting.Ceftaroline for Severe Methicillin-Resistant Staphylococcus aureus Infections: A Systematic ReviewObservation of "seesaw effect" with vancomycin, teicoplanin, daptomycin and ceftaroline in 150 unique MRSA strains.Clinical management of Staphylococcus aureus bacteremia: a review.Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Heterogeneity of mprF sequences in methicillin-resistant Staphylococcus aureus clinical isolates: role in cross-resistance between daptomycin and host defense antimicrobial peptides.Impact of the combination of daptomycin and trimethoprim-sulfamethoxazole on clinical outcomes in methicillin-resistant Staphylococcus aureus infections.Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial.Heterogeneity of genetic pathways toward daptomycin nonsusceptibility in Staphylococcus aureus determined by adjunctive antibioticsAmpicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium.Beta-Lactamase Repressor BlaI Modulates Staphylococcus aureus Cathelicidin Antimicrobial Peptide Resistance and VirulenceEvaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic ModelEvolving resistance among Gram-positive pathogensDaptomycin non-susceptible, vancomycin-intermediate Staphylococcus aureus endocarditis treated with ceftaroline and daptomycin: case report and brief review of the literature.High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis.Poorly Cross-Linked Peptidoglycan in MRSA Due to mecA Induction Activates the Inflammasome and Exacerbates Immunopathologyβ-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives.Penicillin Binding Protein 1 Is Important in the Compensatory Response of Staphylococcus aureus to Daptomycin-Induced Membrane Damage and Is a Potential Target for β-Lactam-Daptomycin SynergyActivity of the thiopeptide antibiotic nosiheptide against contemporary strains of methicillin-resistant Staphylococcus aureus.Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall.Multicenter evaluation of the clinical outcomes of daptomycin with and without concomitant β-lactams in patients with Staphylococcus aureus bacteremia and mild to moderate renal impairment.Bacterial Evasion of Host Antimicrobial Peptide DefensesCAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial.Daptomycin in Combination with Ceftolozane-Tazobactam or Cefazolin against Daptomycin-Susceptible and -Nonsusceptible Staphylococcus aureus in an In Vitro, Hollow-Fiber Model.A current perspective on daptomycin for the clinical microbiologist.Fosfomycin Enhances the Activity of Daptomycin against Vancomycin-Resistant Enterococci in an In Vitro Pharmacokinetic-Pharmacodynamic Model.Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream InfectionsMolecular Bases Determining Daptomycin Resistance-Mediated Resensitization to β-Lactams (Seesaw Effect) in Methicillin-Resistant Staphylococcus aureus.β-Lactams enhance vancomycin activity against methicillin-resistant Staphylococcus aureus bacteremia compared to vancomycin alone.Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureusClassical β-Lactamase Inhibitors Potentiate the Activity of Daptomycin against Methicillin-Resistant Staphylococcus aureus and Colistin against Acinetobacter baumannii.Combination therapy with lysin CF-301 and antibiotic is superior to antibiotic alone for treating methicillin-resistant Staphylococcus aureus-induced murine bacteremia.Application of bacterial cytological profiling to crude natural product extracts reveals the antibacterial arsenal of Bacillus subtilis.MRSA: the first half century.Reduced vancomycin susceptibility among clinical Staphylococcus aureus isolates ('the MIC Creep'): implications for therapy.
P2860
Q21131821-4351E24B-35A9-4357-AC92-6E7C2ED6224BQ26749376-FE9E0E69-4D9A-49EC-A8F2-8EB256ACB33FQ26779944-250C7DB6-677B-4C51-8EF7-5A5187D26218Q30452801-7A528394-0D49-498F-9239-EE3F2A1911B6Q33583164-4D3183A2-91B2-49E1-9369-8098675159CAQ33703659-4F5D88F7-5CBA-432C-99EF-1C9B963628AAQ33879066-24332CD6-6A74-43B4-BA6F-98FD68ED5FB9Q33939095-587D5476-03E3-40F1-9B2E-502695D36C3FQ34441035-CB4D82E6-8873-4BFA-BEA3-CA9622C502FFQ34478074-D7EF5885-8CA8-40F6-97EB-F510F81B7638Q34597770-4664240F-D8F0-48EB-A5D5-1EBCDAD1B849Q35169018-F6D05297-3FCF-4A5A-98AD-B6A3E658922CQ35179800-9D657A34-3DF0-41B4-8B8A-261DAD12B626Q35385568-D00B8A9D-28E6-4995-86DF-461FFCCD3D54Q35689222-8EE51516-03B2-4A6C-AC79-472F6AACB61FQ35754856-513401F4-9D85-49B0-8AC3-B41455E359D0Q35859931-C34EF769-DEE0-4BCA-AA9B-E8F5ACDFFF5DQ35999912-205B8C16-31C0-4383-901C-B1163717A667Q36093730-8670C206-560E-4363-8E13-B54F19376CFBQ36171512-1116A4BC-D465-4966-814B-52A9D50D864AQ36289191-09222FA1-E5FB-4E9B-BF2F-D054FCFE1CE8Q36396117-F49A8160-296E-4DF5-B883-A71353E3B502Q36439093-8F62FED1-69EF-4742-914A-752302DD7A9EQ36484539-9F347E29-73A0-441E-9FEB-919A6E530635Q36565462-20FA11C5-C0FA-4F5F-A5C6-3E28E4803987Q36667027-F60EB6D7-7BFC-484B-B453-F786AD26A7C3Q36720179-4679F2C7-0DE7-44A3-BA3D-485C9C5226D5Q36748977-9894B7D3-76C8-45BD-B4F3-E21A7B0D5139Q37023118-A0D43A48-2EC7-4415-84D1-A652BDE7ECB1Q37263289-E5D1D7A6-6820-4962-A0B4-A70D6CA3A3F9Q37287661-F1C87CD0-EBA1-4D7E-9A12-8FBC0A4F55E9Q37287739-55882829-1385-4D4C-BD75-7B27201DB9ACQ37538754-5D456ADF-ED9F-4D5D-8076-99A0816A2A34Q37544579-31D24B00-5B36-4AEE-BEA7-08D3F77535C5Q37588890-09F4DBD7-9302-4D76-A14A-C091C5269B42Q37613061-E731DDEF-CA63-408D-893C-9D6C0D4E28D1Q37696606-38B019E0-C8C3-476A-893A-CEE068B8EF24Q37723081-4AFDDC94-AF5F-4E4A-B8A7-5E0E9A83AFECQ37947249-9A68C08C-A009-458F-9A04-FDDC916CF331Q37982066-7C5F238E-0167-4640-B691-5A29674F7EFC
P2860
Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Use of antistaphylococcal beta ...... of enhanced daptomycin binding
@en
type
label
Use of antistaphylococcal beta ...... of enhanced daptomycin binding
@en
prefLabel
Use of antistaphylococcal beta ...... of enhanced daptomycin binding
@en
P2093
P2860
P356
P1476
Use of antistaphylococcal beta ...... of enhanced daptomycin binding
@en
P2093
Abhay Dhand
Arnold S Bayer
George Sakoulas
Guiquing Wang
Joseph Pogliano
Michael Bolaris
Soo-Jin Yang
P2860
P304
P356
10.1093/CID/CIR340
P407
P50
P577
2011-07-01T00:00:00Z